Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy
Foundation Medicine wins FDA OK for pan-cancer liquid biopsy test
Foundation Medicine Acquires Lexent Bio, Inc., to Accelerate Liquid Biopsy Research and Development, and Advance Cancer Care
![Foundation Medicine review - 7 facts you should know [DECEMBER 2021]](https://nebula.org/blog/wp-content/uploads/2021/12/FoundationOne-CDx-testing-kit.png "Foundation Medicine review - 7 facts you should know [DECEMBER 2021]")
Foundation Medicine review - 7 facts you should know [DECEMBER 2021]
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin | PLOS ONE
Foundation Medicine receives FDA approval for pan-tumour biopsy test
FDA approves Foundation Medicine pan-tumor liquid biopsy test
FoundationOne Liquid CDx
fmi-10k_20171231.htm
With its liquid biopsy approval, Foundation Medicine takes on Guardant | Evaluate
FDA Approves Blood Tests That Can Help Guide Cancer Treatment - NCI
Foundation Medicine on LinkedIn: Join Foundation Medicine's Lucas Dennis, VP of Franchise Development, for…
Comprehensive genomic profiling in oncology – from vision to reality | Latest news for Doctors, Nurses and Pharmacists | Pharmacy
Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer | Nature Communications
AACR 2019 – Foundation Medicine sets the scene for liquid biopsy approval | Evaluate
Foundation Medicine Announces Commercial Launch of Solid Tumor Liquid Biopsy
Foundation Medicine Introduces FoundationOne®Liquid, the Latest Advance in the Company's Liquid Biopsy Test for Solid Tumors in Patients with Advanced Cancer | Technology Networks
FoundationOne®CDx Technical Information Foundation Medicine, Inc. 150 Second Street, Cambridge, MA 02141 Phone: 617.418.2200 I
Latest Medical News
Foundation Medicine Liquid Biopsy Gets FDA Okay – ISPE Boston
Latest Medical News
FoundationOne Liquid CDx
Foundation Medicine to launch liquid biopsy companion diagnostic following FDA approval - MedCity News
Multi-gene Testing (NGS) for PIK3CA Mutations
